Clinical trial NCT03533179 - References

Drug Overdose — Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition

Citation(s)

•   Bailey B
  Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review. J Toxicol Clin Toxicol. 2003;41(5):595-602. Review.
•   Beta blocker poisoning - UpToDate
  https://www.uptodate.com/contents/beta-blocker-poisoning? search=beta%20blocker%20overdose&source=search_result&selectedTitle=1~14&usage_type=default&display_rank=1 (accessed 14 Feb 2018).
•   Brubacher JR
  62. ß-adrenergic antagonists. In: Hoffman RS, Howland MA, Lewin NA, et al., eds. Goldfrank's toxicologic emergencies. New York: : McGraw-Hill Education 2015. 856-69.
•   Graudins A, Lee HM, Druda D
  Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Br J Clin Pharmacol. 2016 Mar;81(3):453-61. doi: 10.1111/bcp.12763. Epub 2015 Oct 30. Review.
•   Medhus AW, Lofthus CM, Bredesen J, Husebye E
  Gastric emptying: the validity of the paracetamol absorption test adjusted for individual pharmacokinetics. Neurogastroenterol Motil. 2001 Jun;13(3):179-85.
•   Parmley WW, Glick G, Sonnenblick EH
  Cardiovascular effects of glucagon in man. N Engl J Med. 1968 Jul 4;279(1):12-7.
•   Reilly CS, Wood M, Koshakji RP, Wood AJ
  Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade. Clin Pharmacol Ther. 1985 Nov;38(5):579-85.
•   Rodgers RL
  Glucagon and cyclic AMP: time to turn the page? Curr Diabetes Rev. 2012 Sep;8(5):362-81. Review.
•   St-Onge M, Dubé PA, Gosselin S, Guimont C, Godwin J, Archambault PM, Chauny JM, Frenette AJ, Darveau M, Le Sage N, Poitras J, Provencher J, Juurlink DN, Blais R
  Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol (Phila). 2014 Nov;52(9):926-44. doi: 10.3109/15563650.2014.965827. Epub 2014 Oct 6. Review.
•   Yagami T
  Differential coupling of glucagon and beta-adrenergic receptors with the small and large forms of the stimulatory G protein. Mol Pharmacol. 1995 Nov;48(5):849-54.

A Randomized, Participant-blinded Five-arm Crossover Study With Blinded Outcome Assessment Investigating Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition.

Details for clinical trial NCT03533179